{"id":"W3007839305","doi":"10.1200/jco.2020.38.6_suppl.439","title":"Results from BLASST-1 (Bladder Cancer Signal Seeking Trial) of nivolumab, gemcitabine, and cisplatin in muscle invasive bladder cancer (MIBC) undergoing cystectomy.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":138,"is_retracted":false,"has_abstract":true,"ca_institutions":"Genome British Columbia","funders":"","keywords":"Medicine; Cystectomy; Nivolumab; Bladder cancer; Gemcitabine; Oncology; Internal medicine; Cisplatin; Population; Clinical endpoint; Urology; Chemotherapy; Cancer; Immunotherapy; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001195333,0.000272641,0.002179295,0.0001567116,0.00004582456,0.00001553736,0.0001902789,0.0004882414,0.0004643177],"category_scores_gemma":[0.003521286,0.0002127868,0.0004003951,0.0003195493,0.0002362098,0.0001953631,0.0001023527,0.001146723,0.000005146878],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000257115,"about_ca_system_score_gemma":0.004566337,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002915338,"about_ca_topic_score_gemma":0.007176836,"domain_scores_codex":[0.9948035,0.0005286764,0.003312595,0.0004600008,0.0005468319,0.0003483897],"domain_scores_gemma":[0.9918057,0.004753408,0.002328975,0.0001957892,0.0004023162,0.0005137974],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4533409,0.004460011,0.1870899,0.0003761269,0.006368921,0.003064072,0.006887649,0.0009832203,0.0127449,0.00003692832,0.01176481,0.3128825],"study_design_scores_gemma":[0.5792053,0.03941049,0.3563605,0.001832088,0.003014193,0.0000731593,0.001720321,0.001526152,0.001927654,0.0005731174,0.01378356,0.00057349],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9809794,0.002225699,0.00009624365,0.01324793,0.001023679,0.0005919464,0.000117915,0.00001277132,0.00170438],"genre_scores_gemma":[0.98821,0.004310905,0.001108743,0.003751585,0.002422088,0.00002143213,0.000007028176,0.00003968602,0.0001285414],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.312309,"threshold_uncertainty_score":0.8677193,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1345553341513558,"score_gpt":0.4258172032994331,"score_spread":0.2912618691480773,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}